Sponsors should consider the potential benefits of DCT elements as early as possible in the rare disease drug development process
- Information and Resources
- Publications
- White Paper | Decentralization and Innovation approaches to advance Rare…
Sponsors should consider the potential benefits of DCT elements as early as possible in the rare disease drug development process
This site uses cookies to personalize and customize your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.
